Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy

BACKGROUND AND AIMS: Clinical trials of therapy against chronic hepatitis C virus (HCV) infection including boceprevir (BOC) or telaprevir (TVR) plus pegylated interferon and ribavirin (PR) have reported considerably higher response rates than those achieved with PR alone. This study sought to evalu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PLoS One
Main Authors: Neukam, Karin, Munteanu, Daniela I., Rivero-Juárez, Antonio, Lutz, Thomas, Fehr, Jan, Mandorfer, Mattias, Bhagani, Sanjay, López-Cortés, Luis F., Haberl, Annette, Stoeckle, Marcel, Márquez, Manuel, Scholten, Stefan, de los Santos-Gil, Ignacio, Mauss, Stefan, Rivero, Antonio, Collado, Antonio, Delgado, Marcial, Rockstroh, Juergen K., Pineda, Juan A.
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2015
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4414348/
https://ncbi.nlm.nih.gov/pubmed/25923540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0125080
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki